Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant drugs added to lidocaine for axillary block in distal radius fracture surgery
IRCT20180301038909N4Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, dexmedetomidine, magnesium sulfate and dexamethasone in distal forearm fracture (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Duration of analgesia, Opioid consumption and 1 more. Started Aug 2026; status: completed.
02
Drugs
lidocainedexmedetomidinemagnesium sulfatedexamethasone
03
Conditions
distal forearm fracture
Beyond the preview
Go deeper on IRCT20180301038909N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180301038909N4.